<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01050166</url>
  </required_header>
  <id_info>
    <org_study_id>CD MRI IKEM 1</org_study_id>
    <nct_id>NCT01050166</nct_id>
  </id_info>
  <brief_title>MRI Imaging of Labeled Human Islets Transplanted Into the Liver</brief_title>
  <official_title>Phase 1 Study to Test Safety and Efficacy of Magnetic Resonance Imaging of Human Labeled Islets Transplanted Into the Liver in Type 1 Diabetic Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Frantisek Saudek</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institute for Clinical and Experimental Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether human islets labeled by iron contrast agents&#xD;
      could be imaged using magnetic resonance after transplantation into the liver of Type 1&#xD;
      diabetic recipients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Islet transplantation represents approved therapeutic approach in selected Type 1 diabetic&#xD;
      recipients with syndrome of hypoglycaemia unawareness. Existing imaging methods are not&#xD;
      sufficient to provide adequate information about amount and fate of islets transplanted into&#xD;
      the liver. Labeling of islets with superparamagnetic contrast agent ferucarbotran&#xD;
      significantly shortens T2 relaxing time and therefore increase the contrast between islets&#xD;
      and liver tissue in magnetic resonance imaging. In consequence, islets transplanted into&#xD;
      liver could be easily detectable like hypotensive areas dispersed throughout the liver. MRI&#xD;
      examination will be done on 1, 2, 4 weeks and 3, 6 and 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 15, 2008</start_date>
  <completion_date type="Actual">December 31, 2012</completion_date>
  <primary_completion_date type="Actual">December 15, 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evidence of safety and efficacy of MRI imaging of transplanted human labeled islets</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">8</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Labeled islets</arm_group_label>
    <description>Type 1 diabetic recipients after islet transplantation with islets labeled by iron contrast agent</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transplantation of labeled islets</intervention_name>
    <arm_group_label>Labeled islets</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort will be selected from residents of Czech republic&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Type 1 diabetes mellitus&#xD;
&#xD;
          -  normal renal parameters&#xD;
&#xD;
          -  hypoglycaemia unawareness or rapid progression of diabetic retinopathy or neuropathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute and chronic liver disease&#xD;
&#xD;
          -  malignancy&#xD;
&#xD;
          -  acute infection&#xD;
&#xD;
          -  serious cardiovascular disease&#xD;
&#xD;
          -  coagulopathy&#xD;
&#xD;
          -  portal hypertension&#xD;
&#xD;
          -  presence of metal protesis, cardio-stimulators, or other metal material in the body&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frantisek Saudek, MD, DrSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Clinical and Experimental Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes Center, Institute for Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>14000</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <results_reference>
    <citation>Saudek F, Jirák D, Girman P, Herynek V, Dezortová M, Kríz J, Peregrin J, Berková Z, Zacharovová K, Hájek M. Magnetic resonance imaging of pancreatic islets transplanted into the liver in humans. Transplantation. 2010 Dec 27;90(12):1602-6.</citation>
    <PMID>21197715</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 14, 2010</study_first_submitted>
  <study_first_submitted_qc>January 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 15, 2010</study_first_posted>
  <last_update_submitted>April 22, 2021</last_update_submitted>
  <last_update_submitted_qc>April 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Institute for Clinical and Experimental Medicine</investigator_affiliation>
    <investigator_full_name>Frantisek Saudek</investigator_full_name>
    <investigator_title>MD., prof.</investigator_title>
  </responsible_party>
  <keyword>islet transplantation</keyword>
  <keyword>magnetic resonance</keyword>
  <keyword>Type 1 DM</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

